Dornier MedTech Systems GmbH, a leading name in the medical technology sector, is headquartered in Germany and operates extensively across Europe and North America. Founded in 1980, the company has established itself as a pioneer in the development of innovative solutions for urology and other medical fields. Dornier is renowned for its advanced lithotripsy systems, which utilise cutting-edge technology to provide non-invasive treatment for kidney stones. Their commitment to research and development has led to significant milestones, including the introduction of the first extracorporeal shock wave lithotripter. With a strong market position, Dornier MedTech is recognised for its high-quality products and exceptional service, making it a trusted partner for healthcare professionals worldwide. The company continues to push the boundaries of medical technology, ensuring better patient outcomes and enhancing the efficiency of medical procedures.
How does Dornier MedTech Systems GmbH's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Dornier MedTech Systems GmbH's score of 36 is higher than 61% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Dornier MedTech Systems GmbH, headquartered in Germany (DE), currently does not have specific carbon emissions data available for recent years. As a current subsidiary of Accuron Technologies Limited, any emissions data or climate commitments may be influenced by the parent company's initiatives. However, there are no documented reduction targets or climate pledges from Dornier MedTech Systems GmbH at this time. The absence of emissions data suggests that the company may still be in the process of establishing its climate strategy or reporting framework. In the context of the medical technology industry, companies are increasingly focusing on sustainability and carbon reduction, often aligning with broader industry standards and frameworks such as the Science Based Targets initiative (SBTi) and the Carbon Disclosure Project (CDP). As the company develops its climate commitments, it may consider setting specific reduction targets to align with industry best practices and contribute to global climate goals.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Dornier MedTech Systems GmbH has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
